Showing 1 - 6 results of 6 for search 'Batt K', query time: 0.03s Refine Results
  1. 1
    The Importance of Clinical Context and Consistency in Methodology When Using Matching-Adjusted Indirect Comparisons (MAICs) to Compare Outcomes

    The Importance of Clinical Context and Consistency in Methodology When Using Matching-Adjusted Indirect Comparisons (MAICs) to Compare Outcomes by Batt K, Klamroth R, Mancuso ME, Tiede A, Mantovani LG

    Published 2024-09-01
    Get full text
    Article
  2. 2
    A Delphi Consensus Approach for Difficult-to-Treat Patients with Severe Hemophilia A without Inhibitors

    A Delphi Consensus Approach for Difficult-to-Treat Patients with Severe Hemophilia A without Inhibitors by Veeranki SP, Pednekar P, Graf M, Tuly R, Recht M, Batt K

    Published 2021-10-01
    Get full text
    Article
  3. 3
    Indirect Treatment Comparison of Damoctocog Alfa Pegol versus Turoctocog Alfa Pegol as Prophylactic Treatment in Patients with Hemophilia A

    Indirect Treatment Comparison of Damoctocog Alfa Pegol versus Turoctocog Alfa Pegol as Prophylactic Treatment in Patients with Hemophilia A by Vashi P, Batt K, Klamroth R, Mancuso ME, Majewska R, Tiede A, Mantovani LG

    Published 2021-11-01
    Get full text
    Article
  4. 4
    Internal consistency and item-total correlation of patient-reported outcome instruments and hemophilia joint health score v2.1 in US adult people with hemophilia: results from the Pain, Functional Impairment, and Quality of life (P-FiQ) study

    Internal consistency and item-total correlation of patient-reported outcome instruments and hemophilia joint health score v2.1 in US adult people with hemophilia: results from the... by Wang M, Batt K, Kessler C, Neff A, Iyer NN, Cooper DL, Kempton CL

    Published 2017-10-01
    Get full text
    Article
  5. 5
    Matching-adjusted indirect comparisons of annualized bleeding rate and utilization of BAY 94-9027 versus three recombinant factor VIII agents for prophylaxis in patients with severe hemophilia A

    Matching-adjusted indirect comparisons of annualized bleeding rate and utilization of BAY 94-9027 versus three recombinant factor VIII agents for prophylaxis in patients with sever... by Batt K, Gao W, Ayyagari R, Deschaseaux C, Vashi PB, Yao Z, Wang Y, Kessabi S, Klamroth R

    Published 2019-06-01
    Get full text
    Article
  6. 6
    Reliability of patient-reported outcome instruments in US adults with hemophilia: the Pain, Functional Impairment and Quality of life (P-FiQ) study

    Reliability of patient-reported outcome instruments in US adults with hemophilia: the Pain, Functional Impairment and Quality of life (P-FiQ) study by Kempton CL, Wang M, Recht M, Neff A, Shapiro AD, Soni A, Kulkarni R, Buckner TW, Batt K, Iyer NN, Cooper DL

    Published 2017-09-01
    Get full text
    Article

Search Tools: